Abstract-Interleukin (IL)-18 is the interferon-␥-inducing factor and has other proinflammatory properties. The precise role of IL-18 in immunoinflammatory diseases remains poorly understood. In this study, we show that in vivo electrotransfer of an expression-plasmid DNA encoding for murine IL-18 binding protein (BP) (the endogenous inhibitor of IL-18) prevents fatty streak development in the thoracic aorta of apoE knockout mice and slows progression of advanced atherosclerotic plaques in the aortic sinus. More importantly, transfection with the IL-18BP plasmid induces profound changes in plaque composition (decrease in macrophage, T cell, cell death, and lipid content and increase in smooth muscle cell and collagen content) leading to a stable plaque phenotype. These results identify for the first time a critical role for IL-18/IL-18BP regulation in atherosclerosis and suggest a potential role for IL-18 inhibitors in reduction of plaque development/progression and promotion of plaque stability. Key Words: atherosclerosis Ⅲ inflammation Ⅲ interleukin Ⅲ cytokines A therosclerosis is the leading cause of mortality in industrialized countries and carries an important socioeconomic burden. Unabated inflammatory mechanisms are responsible for changes in atherosclerotic plaque composition leading to plaque disruption and to the occurrence of acute ischemic syndromes, namely myocardial infarction and stroke. 1 Interleukin (IL)-18 is an inducer of interferon (IFN)-␥ with potent activities on inflammatory and vascular cells 2 and is thought to contribute to the pathogenesis of chronic immunoinflammatory processes. 3,4 Interestingly, we have recently detected increased production of IL-18 by macrophages and smooth muscle cells in unstable human atherosclerotic plaques that were responsible for strokes compared with stable plaques from asymptomatic patients. 5 An endogenous IL-18 binding protein (IL-18BP) that neutralizes IL-18 has been identified. 6 However, the role of IL-18BP in the modulation of atherogenesis and other chronic immunoinflammatory diseases in vivo is currently unknown. In this study, we examined the role of IL-18/IL-18BP in a wellvalidated model of atherosclerosis. Materials and Methods In Vivo Intramuscular Electrotransfer of Murine IL-18BP Expression PlasmidFourteen male C57BL/6 apoE knockout mice, 14 weeks old, received at 3-week intervals, 3 injections with the murine IL-18BP expression plasmid, pcDNA3-mIL18BP. The control mice (nϭ19) were injected with the control empty plasmid. Murine IL-18BP isoform d cDNA (accessory number #AF110803), isolated as described, 6 was subcloned into the EcoR1/Not1 sites of mammalian cell expression vector pcDNA3 under the control of the cytomegalovirus promotor (Invitrogen). Control vector was a similar construct devoid of therapeutic cDNA. The construct with mIL-18BP isoform d in pCDNA3 plasmid was tested for expression and activity. This was performed using culture supernatants obtained from HEK 293/Ebna cells transfected with mIL-18BPd in pCDNA3 vector. We verified...
The public availability of numerous microbial genomes is enabling the analysis of bacterial biology in great detail and with an unprecedented, organism-wide and taxon-wide, broad scope. Streptococcus pneumoniae is one of the most important bacterial pathogens throughout the world. We present here sequences and functional annotations for 2.1-Mbp of pneumococcal DNA, covering more than 90% of the total estimated size of the genome. The sequenced strain is a clinical isolate resistant to macrolides and tetracycline. It carries a type 19F capsular locus, but multilocus sequence typing for several conserved genetic loci suggests that the strain sequenced belongs to a pneumococcal lineage that most often expresses a serotype 15 capsular polysaccharide. A total of 2,046 putative open reading frames (ORFs) longer than 100 amino acids were identified (average of 1,009 bp per ORF), including all described two-component systems and aminoacyl tRNA synthetases. Comparisons to other complete, or nearly complete, bacterial genomes were made and are presented in a graphical form for all the predicted proteins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.